LodeJanSwinnenMD

Clinical Trials

• SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma Start of enrollment: 1994 Jun 01

  Completed

  Phase 2

• SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Start of enrollment: 1995 May 01

  Completed

  Phase 2

• S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma Start of enrollment: 1998 Nov 01

  Completed

  Phase 2

• Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2001 Apr 01

  Completed

  Early Phase 1

• Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant Start of enrollment: 2004 Feb 01

  Completed

  Phase 2

• Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2004 Mar 01

  Completed

  Phase 2

• Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2006 Sep 26

  Completed

  Phase 2

• Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma Start of enrollment: 2005 Jan 01

  Completed

  Phase 2

• Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2007 Aug 23

  Terminated

  Phase 2

• R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2009 Jan 01

  Terminated

  Phase 2

• BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance Start of enrollment: 2014 Jan 07

  Terminated

  Phase 2

• Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma Start of enrollment: 2022 Jun 21

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all